Mechanisms and Effects of Prenatal Maternal Affect on Pregnancy and Infant Development
Funded by NICHD
Joint PIs: Chris Dunkel Schetter, PhD, University of California, Los Angeles & Mary Coussons-Read, PhD, University of Colorado, Colorado Springs
CoPIs: Calvin Hobel, MD, Cedars Sinai Medical Center & Camille Hoffman, MD, MSCS, University of Colorado, Denver
CoInv: Elysia Davis, PhD, University of Denver & Michelle Okun, PhD, University of Colorado, Colorado Springs
Project Coordinator: Roberta Mancuso, PhD, Regis University
This project will provide important evidence concerning the relationships between antenatal maternal mood disorders, pregnancy-specific stress, and poor pregnancy outcomes as well as what these relationships mean for infant immunologic and neurobehavioral development. The research will test the hypothesis that prenatal maternal mood disorders and symptoms increase the risk of poor pregnancy outcomes and compromise infant behavioral and immunological development in the first year of life, and that activation of the HPA axis and increased inflammatory activity in the perinatal period plays a significant role in these effects.
Additional exploratory analyses concern: (1) the role of vitamin D in the relationships under investigation, given growing evidence of its involvement in inflammation, mood disorders, and birth outcome; (2) if and how residence at moderate altitude (5280 feet above sea level) may play a role in these effects; and (3) how prenatal maternal biopsychosocial variables may impact maternal mood, stress, and neural-immune status in the postpartum.
Pregnant women between 1 and 12 weeks gestation are being recruited for this project from the Denver Health and Hospital Authority (DHHA) in Denver, CO and from Cedars Sinai Medical Center (CSMC) in Los Angeles (LA), CA. Women undergo three assessments, one per trimester, including interview, biosamples, and ultrasound. Medical charts of prenatal visits and labor and delivery will be abstracted. Mothers and infants are assessed at 1, 6, and 12 months after birth by interview, observation, developmental assessments, and biosamples.
